Equities

STERIS plc

STERIS plc

Actions
Health CareMedical Equipment and Services
  • Price (USD)215.15
  • Today's Change-0.62 / -0.29%
  • Shares traded172.41k
  • 1 Year change+6.22%
  • Beta0.8329
Data delayed at least 15 minutes, as of Nov 22 2024 17:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.

  • Revenue in USD (TTM)5.12bn
  • Net income in USD602.62m
  • Incorporated2016
  • Employees18.18k
  • Location
    STERIS plcBlock a Riverside IV70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
  • Phone+353 12322000
  • Websitehttps://www.steris.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Globus Medical Inc2.48bn91.51m13.47bn5.00k127.952.8438.505.430.66360.663618.0829.940.47471.284.58495,719.201.756.901.997.4558.1471.733.6914.051.64--0.09740.0053.3417.08-35.39-4.725.57--
Revvity Inc2.72bn258.26m13.52bn11.50k53.041.7119.694.972.092.0622.0664.880.20782.894.37236,657.001.974.762.155.3955.4457.199.4915.342.9711.960.28696.52-16.95-0.1982-64.99-5.28-2.690.00
Avantor Inc6.82bn309.60m13.86bn14.50k44.812.5019.392.030.45440.454410.018.160.5325.566.09470,331.002.422.972.753.3533.5333.444.545.061.063.290.46980.00-7.263.51-51.52--31.17--
Baxter International Inc11.77bn225.00m16.83bn60.00k74.632.1412.841.430.4420.21423.1015.420.41052.915.42196,133.300.81980.19421.050.233338.4338.202.000.36741.093.810.61961,398.942.125.9497.15--0.9829.71
Align Technology, Inc.3.96bn441.57m17.04bn21.61k38.904.3329.264.305.875.8752.6352.760.62454.324.14183,272.506.9616.3410.3924.1469.9871.7211.1523.161.14--0.000.003.4214.4523.092.15-4.46--
Hologic Inc4.03bn789.50m18.28bn6.99k23.713.5616.644.543.323.3216.9722.090.44062.726.57--8.6313.129.8415.2056.2560.8219.5924.753.0364.450.3307---0.00253.6673.14--4.30--
Insulet Corp1.98bn420.90m18.38bn3.00k45.5516.4436.839.265.755.7525.9615.940.72231.426.14661,300.0015.322.7118.563.1469.3665.8121.224.282.8098.710.55570.0030.0224.664,384.78128.77-7.63--
Cooper Companies Inc3.80bn359.30m19.90bn15.00k55.642.5127.035.231.801.8019.0239.800.31961.705.56253,606.703.0210.063.2911.3466.3665.549.4529.001.185.460.24930.34698.617.24-23.74-3.6615.180.00
Steris PLC5.12bn602.62m21.30bn18.18k35.513.2319.234.166.084.3851.6266.800.47583.865.49281,655.405.625.196.105.6843.0143.6411.8110.971.558.290.252836.5613.2813.06-1.0712.6713.698.83
Zimmer Biomet Holdings Inc7.60bn1.08bn21.58bn18.00k20.651.7510.482.845.255.2536.8762.000.35380.91365.38421,972.205.052.215.822.5271.7871.2514.287.280.69877.520.342538.906.55-1.40252.86--9.440.00
Illumina Inc4.39bn-1.58bn21.73bn10.59k--10.25--4.95-10.00-10.0027.6113.360.54412.666.17414,542.00-19.63-6.20-23.16-7.2863.9466.39-36.08-15.481.8538.440.4834---1.756.2173.64---7.91--
Waters Corp2.91bn622.64m21.88bn7.90k35.1613.6526.867.5310.4810.4848.8927.000.6452.204.47367,740.1013.8219.7716.7225.2959.7358.4521.4323.381.3810.110.53250.00-0.52294.09-9.261.534.72--
West Pharmaceutical Services Inc.2.88bn499.60m23.24bn10.60k47.558.4536.648.086.756.7538.8637.960.77434.505.51271,358.5013.0215.6115.1618.6534.8738.0616.8118.472.23--0.069510.692.1811.432.2823.7628.166.20
DexCom Inc3.95bn680.80m29.08bn9.60k45.4514.7032.567.361.641.649.525.070.61072.764.42411,875.0010.518.3014.2810.5062.1065.9017.2214.142.12--0.55790.0024.4928.5658.70--28.66--
Data as of Nov 22 2024. Currency figures normalised to STERIS plc's reporting currency: US Dollar USD

Institutional shareholders

44.98%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202411.61m11.78%
Massachusetts Financial Services Co.as of 30 Sep 20246.34m6.42%
BlackRock Fund Advisorsas of 30 Sep 20245.63m5.71%
WCM Investment Management LLCas of 30 Sep 20244.68m4.75%
SSgA Funds Management, Inc.as of 30 Sep 20244.07m4.12%
Generation Investment Management LLPas of 30 Sep 20242.82m2.86%
APG Asset Management NVas of 30 Sep 20242.73m2.77%
Morgan Stanley Investment Management Ltd.as of 30 Sep 20242.49m2.52%
Geode Capital Management LLCas of 30 Sep 20242.30m2.34%
Janus Henderson Investors US LLCas of 30 Sep 20241.68m1.70%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.